6Knochenhauer ES, Key TJ, Kahsar-Miller R Prevalence of the polycystic ovary syrdrome in unselected black and white women of the Southeastem United States : A prospective study. J Clin Endocrinol Metab 1998; 83: 3078-82.
7Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999;, 51:779-86.
8Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, etct, A simple Screening Approach for Assessing Comunity Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka, American Journal of Epidemiology, Am J Epidemiol, 2008 Aug 1; 168(3):321-8.
9The Rotterdam ESHRE/ASRM-sponsored RIB consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(B2(B). Run Reprod, 2004, 19 (1). 41-47.
6seli E, duleba AJ. Optimizing ovulation induction in women with poly- cyst ovary syndrome [ J 1. Curl Opin Obstet GynecoI, 2002, 14 ( 3 ) : 245.
7Kafali H, Iriadam M, Ozardl I, et al. Letrozole-in- duced polycystic ovaries in the rat: a new model for cystic ovarian disease[J]. Arch Med Res, 2004, 35(2): 103-108.
8Irfan Yavasoglu, Mert Kucuk, Adil Coskun, et al. Polycystic ovary syndrome and prolactinoma associa- tion[J]. Intern Med, 2009, 48(8): 611-615.
9Kafali H, Iriadam M, Ozardl I, et al. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease[J]. Arch Med Res, 2004, 35(2): 103-108.
10Yavasoglu I, Kucuk M, Coskun A, et al. Polycystic ovary syndrome and prolactinoma association [J]. Intern Med, 2009, 48(8): 611-615.
